Evidence map›Paper›PMID 40579233›Full record

ReviewFuture microbiology2025

The advantages of

Hanieh Safarzadeh, Amir Aliramezani, Arian Rahimi, Bahareh Yousefi, Siamak Heidarzadeh

Abstract readReview
In one paragraph

Review in Future microbiology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed.

  1. Article
  2. [Research progress on the effects of maternal gut microbiota in gestational obesity on offspring and potential mechanisms].Zhongguo dang dai er ke za zhi = Chinese journal of contemporary pediatrics · 2026
    Review
  3. Article
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Hanieh SafarzadehDepartment of Microbiology and Virology, School of Medicine, Zanjan University of Medical Sciences, Zanjan, Iran.ORCID 0009-0004-4698-3599
Amir AliramezaniDepartment of Microbiology, Faculty of Biochemistry, Biophysics, and Biotechnology, Jagiellonian University, Kraków, Poland.ORCID 0000-0002-0252-0945
Arian RahimiDepartment of Biochemistry and Molecular Biology, School of Life Sciences, USTC, Hefei, China.ORCID 0000-0002-1115-7463
Bahareh YousefiDepartment of Biology, Science and Research Branch, Islamic Azad University, Tehran, Iran.ORCID 0009-0001-9974-2252
Siamak HeidarzadehDepartment of Microbiology and Virology, School of Medicine, Zanjan University of Medical Sciences, Zanjan, Iran.ORCID 0000-0003-3782-2916

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

In recent years, the incidence of metabolic disorders has exponentially increased worldwide mainly due to the misfunctioning of chemical reactions. Gestational diabetes mellitus (GDM) occurred during pregnancy when placenta prevent absorption of sufficient insulin in mother's body. Although this disorder usually disappears after delivery, it could raise the probability of developing complications in the future. GDM is associated with adverse effects on women and their children, such as obesity, cardiovascular disease, and type 2 diabetes. On the other hand, administration of probiotics as a live microorganism with the wide array of health values could contribute to restore and stabilize gut microbiota and subsequently regulate essential internal functions such as development of immunity. In this review, we focus primarily on some causes and effects of GDM in pregnant women and then

Indexed as

Diabetes, GestationalFaecalibacteriumProbioticsAnimalsBiomarkersDiabetes Mellitus, Type 2FemaleGastrointestinal MicrobiomeHumansPregnancyBiomarkersFaecalibacterium prasnitziigestational diabetes mellitus (GDM)Gut microbiotaIntestinal barrier functionMicrobiome dysbiosisProbiotic potential

Identifiers

PMID40579233
PMCPMC12239820

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.